#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14584	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2104	688.3	0	.	n	.	0	A662G	SNP	662	662	A	894	894	G	835	G,A	776,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14584	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2104	688.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1682	1682	T	791	T,C	729,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14584	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2104	688.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	895	C,T,G	836,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27170	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3494	773.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1636	1636	A	974	A	890	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27170	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3494	773.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2270	2270	C	825	C	765	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27170	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3494	773.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2344	2344	A	858	A,G	800,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27170	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3494	773.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2896	2896	C	885	C	816	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	14	blaTEM	861	586	99.66	blaTEM.l15.c30.ctg.1	586	2.0	0	.	p	.	0	P12S	NONSYN	34	36	CCC	33	35	TCC	1;1;1	T;C;C	1;1;1	.	Betalactam resistance
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1882	folP	852	852	99.88	folP.l15.c4.ctg.1	1529	122.9	0	.	p	.	0	A204V	NONSYN	610	612	GCA	912	914	GTA	203;203;201	G;T;A	195;195;194	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1882	folP	852	852	99.88	folP.l15.c4.ctg.1	1529	122.9	1	SNP	p	R228S	0	.	.	682	684	CGC	984	986	CGC	198;200;201	C;G,A,T;C	184;182,1,1;183	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5094	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3402	149.2	1	SNP	p	S91F	0	.	.	271	273	TCC	603	605	TCC	174;173;173	T;C;C	154;151;154	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5094	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3402	149.2	1	SNP	p	D95G	0	.	.	283	285	GAC	615	617	GAC	163;161;163	G;A;C	146;146;147	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5094	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3402	149.2	1	SNP	p	D95N	0	.	.	283	285	GAC	615	617	GAC	163;161;163	G;A;C	146;146;147	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	531	1608	mtrR	633	633	99.68	mtrR.l15.c30.ctg.1	1303	122.9	0	.	p	.	0	N71fs	FSHIFT	211	211	A	474	474	A	236	A	210	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	792	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1094	72.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4526	parC	2304	2304	99.78	parC.l15.c30.ctg.1	3005	150.0	0	.	p	.	0	G459S	NONSYN	1375	1377	GGT	1798	1800	AGT	186;185;185	A;G;T	178;172;174	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4526	parC	2304	2304	99.78	parC.l15.c30.ctg.1	3005	150.0	1	SNP	p	D86N	0	.	.	256	258	GAC	679	681	GAC	180;178;180	G;A;C	165;163;166	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4526	parC	2304	2304	99.78	parC.l15.c30.ctg.1	3005	150.0	1	SNP	p	S87R	0	.	.	259	261	AGT	682	684	AGT	181;179;181	A;G;T	168;167;167	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4526	parC	2304	2304	99.78	parC.l15.c30.ctg.1	3005	150.0	1	SNP	p	S87I	0	.	.	259	261	AGT	682	684	AGT	181;179;181	A;G;T	168;167;167	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4526	parC	2304	2304	99.78	parC.l15.c30.ctg.1	3005	150.0	1	SNP	p	S87W	0	.	.	259	261	AGT	682	684	AGT	181;179;181	A;G;T	168;167;167	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4526	parC	2304	2304	99.78	parC.l15.c30.ctg.1	3005	150.0	1	SNP	p	S88P	0	.	.	262	264	TCC	685	687	TCC	181;184;186	T;C;C	167;168;170	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4030	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2554	156.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1444	1446	GGC	202;200;200	G;G,A;C	181;179,1;178	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	3908	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2456	158.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1298	1300	GCA	233;238;238	G;C;A	207;207;212	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3908	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2456	158.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1301	1303	ATC	238;238;237	A;T;C	211;212;209	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3908	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2456	158.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1313	1315	GTG	244;242;243	G;T;G	217;215;217	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3908	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2456	158.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1313	1315	GTG	244;242;243	G;T;G	217;215;217	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3908	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2456	158.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1817	1819	ACC	184;184;184	A;C;C	169;171;173	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3908	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2456	158.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1871	1873	GCG	205;206;205	G;C,T;G	185;170,1;176	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3908	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2456	158.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1871	1873	GCG	205;206;205	G;C,T;G	185;170,1;176	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3908	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2456	158.2	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1994	1996	GGT	202;201;200	G;G;T	185;186;184	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3908	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2456	158.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2003	2005	GGC	203;200;201	G;G;C	189;185;186	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3908	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2456	158.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2021	2023	CCG	182;185;185	C,T,G;C;G	124,1,1;156;145	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5896	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3119	188.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1888	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1696	110.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	371	373	GGC	138;137;140	G;G;C,T	128;127;130,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1888	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1696	110.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	553	553	C	143	C	129	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	I45V	NONSYN	133	135	ATT	413	415	GTT	253;257;256	G;T;T	235;238;237	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	G46V	NONSYN	136	138	GGC	416	418	GTC	254;253;253	G;T,G;C	237;238,1;238	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	N121S	NONSYN	361	363	AAC	641	643	AGC	218;216;214	A,G;G,A;C	206,1;205,1;204	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	N122K	NONSYN	364	366	AAC	644	646	AAA	214;215;217	A;A;A,C	203;207;206,2	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	671	673	TAT	221;221;220	T;A,T;T,A	213;212,1;203,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	N134E	NONSYN	400	402	AAT	680	682	GAG	214;215;213	G,A;A;G,T	203,1;202;201,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	V135L	NONSYN	403	405	GTG	683	685	CTT	214;213;213	C,G;T;T,G	201,1;203;200,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	G140K	NONSYN	418	420	GGA	698	700	AAA	224;223;224	A,G;A,G;A	212,1;211,1;210	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	707	709	GAA	232;229;229	G,C;A;A	214,1;211;211	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	V151A	NONSYN	451	453	GTA	731	733	GCA	230;228;227	G;C;A	214;214;212	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	G160D	NONSYN	478	480	GGC	758	760	GAC	235;234;230	G;A;C	222;219;218	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	K207_M208insK	INS	619	619	A	899	899	A	232	A	217	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	Y211H	NONSYN	631	633	TAT	914	916	CAT	238;235;234	C;A;T	221;219;218	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	A212S	NONSYN	634	636	GCA	917	919	TCA	235;238;241	T;C;A	218;221;222	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2972	porB1b	1038	1038	96.18	porB1b.l15.c17.ctg.1	1472	201.2	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1034	1034	T	233	T	214	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	12462	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4791	259.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2021	2023	CAT	289;293;297	C;A;T	270;275;279	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1270	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	982	128.0	1	SNP	p	V57M	1	.	.	169	171	ATG	432	434	ATG	272;272;273	A;T;G	255;254;256	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
